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Maternal smoking during pregnancy is associated with increased substance abuse in off-
spring. Preclinical research shows that in utero exposure to nicotine, the primary psychoac-
tive compound in tobacco smoke, inﬂuences the neurodevelopment of reward systems
andaltersmotivatedbehaviorinoffspring.Thepresentstudydeterminedifprenatalnicotine
(PN)exposurealteredthesensitivitytothereinforcingandaversiveeffectsofmethamphet-
amine (METH) in offspring using a low dose, intravenous (IV) exposure method. Pregnant
dams were administered nicotine (0.05mg/kg/injection) or prenatal saline (PS) 3/day on
gestational days 8–21, and adult offspring were tested using METH self-administration
(experiment 1) or METH-induced conditioned taste aversion (CTA; experiment 2) pro-
cedures. For METH self-administration, animals were trained to respond for IV METH
(0.05mg/kg/infusion; ﬁxed-ratio 3) and they were tested on varying doses of the reinforcer
(0.0005–1.0mg/kg/infusion). For METH CTA, rats received three saccharin and METH pair-
ings (0, 0.3, or 0.5mg/kg, sc) followed by 14 daily extinction trials. Experiment 1: PN and
PS animals exhibited inverted U-shaped dose-response curves; however, the PN animal’s
curve was shifted to the left, suggesting PN animals were more sensitive to the reinforcing
effects of METH. Experiment 2: METH CTA was acquired in a dose-dependent manner and
the factor of PN exposure was not related to the acquisition or extinction of METH-induced
CTA. There were no sex differences in either experiment. These results indicate that IV
PN-exposed adult offspring exhibited increased sensitivity to IV METH.This suggests that
PN exposure, via maternal smoking, will alter the reinforcing effects of METH during later
stages of development, and furthermore, will inﬂuence substance use vulnerability in adult
human offspring.
Keywords: maternal smoking, prenatal nicotine, intravenous, methamphetamine, self-administration, conditioned
taste aversion
INTRODUCTION
Maternalsmokingduringpregnancyimpartsmultiplehealthrisks
on the fetus (Castles et al.,1999;Ernst et al.,2001;Winzer-Serhan,
2008; Cornelius and Day,2009). Aside from the well documented
effectsofmaternalsmokingtoproducelowbirthweight,restricted
intrauterine growth, and increased incidence of sudden infant
death syndrome, it is also apparent that offspring are at increased
risk of developing substance use disorder. According to clinical
research, tobacco smoke-exposed offspring exhibit an increased
likelihood of drug abuse if they initiate drug taking behaviors
during adolescence (Kandel et al., 1994; Weissman et al., 1999;
Brennan et al.,2002; Buka et al.,2003).
Variousanimalmodelsofprenatalnicotine(PN)exposurehave
been used to elucidate the inﬂuence of nicotine on the neurobe-
havioral development of offspring (Dwyer et al., 2009; Heath and
Picciotto, 2009). In these models, PN is administered to rodents
either continuously via osmotic minipump (Slotkin et al., 1987;
Levin et al., 1996; Franke et al., 2007), orally, through drinking
water(Zhuetal.,1996;Paulyetal.,2004;Pazetal.,2007;Schneider
et al., 2010), or through intravenous (IV) injection (LeSage et al.,
2006; Harrod et al., 2011; Lacy et al., 2011). Multiple experiments
demonstrate that PN exposure alone produces alterations in the
neurodevelopment of the mesocorticolimbic dopamine (DA) sys-
tem,whichinpartmediatesmotivatedbehavior.SuchPN-induced
changes are hypothesized to mediate alterations in the behavioral
repertoire of adolescent and adult offspring exposed to PN (Pauly
et al., 2004; LeSage et al., 2006; Franke et al., 2008; Lacy et al.,
2011). For example, experiments using the continuous route of
PNexposureresultedindecreasedstriatalDAcontentinweanling
rats (Richardson and Tizabi, 1994), increased c-fos expression in
the infralimbic cortex and nucleus accumbens core (Park et al.,
2006), and decreased nicotine-evoked DA release in the nucleus
accumbens shell of adolescent rats (Kane et al., 2004). In drug
self-administration experiments, adolescent offspring exposed to
continuous PN acquired cocaine self-administration at a higher
unit dose of drug relative to prenatal saline (PS) controls. This
ﬁndingsuggeststhatPNexposurealteredthereinforcingeffectsof
cocaine (Franke et al., 2008). Adult, PN-exposed female offspring
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self-administered a greater number of nicotine infusions than PS
rats following a period of forced abstinence, which suggests that
PN-exposed offspring exhibited increased motivation to respond
for nicotine (Levin et al.,2006). Together,these experiments indi-
cate that continuous PN exposure alters the neurodevelopment of
the mesocorticolimbic DA system and that such changes impact
the motivation for drug reward.
Thepresent experimentsdetermined if IV PNexposurealtered
the motivational effects of the highly abused drug methamphet-
amine (METH) in adult offspring. It is of interest to use the
IV route of administration to deliver nicotine because it closely
models the nicotine pharmacokinetics of tobacco smoke inhala-
tion (Russell and Feyerabend, 1978; Mactutus, 1989; Booze et al.,
1999; Benowitz et al.,2009). The elimination half-life for nicotine
0.05mg/kg/injection is approximately 50min (Booze et al.,1999),
andsothismethodrepresentsauniqueexposuremodelinthatthe
dam and fetuses experience the bolus delivery of nicotine to the
brain followed by a rapid and precipitous clearance (Russell and
Feyerabend, 1978; Mactutus, 1989). Moreover, this method may
be used to deliver less overall daily amounts of nicotine relative
to other exposure models, while still providing a translationally
relevant exposure (see Dwyer et al., 2008). IV PN exposure pro-
duced changes in brain-derived neurotrophic factor throughout
themesocorticolimbicDAsystemof adolescentoffspring(Harrod
etal.,2011).Pre-weanlingoffspringexhibitedhypoactivelocomo-
tor activity in response to a novel context (LeSage et al., 2006),
and showed deﬁcits in sensorimotor gating of the acoustic startle
response (Lacy et al., 2011). Furthermore, adult offspring showed
increasedmotivationforsucrosereward,relativetocontrols,when
rats responded according to a progressive-ratio schedule of rein-
forcement;andinthisstudytherewerenoeffectsof prenataltreat-
ment when ﬁxed-ratio (FR) schedules of reinforcement were used
(Lacyetal.,2012).Theseﬁndingsdemonstratethatadministration
of PNviatheIVrouteproduceschangesintheneurodevelopment
of motivational brain systems, and that offspring exhibit behav-
ioral deﬁcits during various stages of neurodevelopment, relative
to controls.
ThepresentexperimentstestedthehypothesisthatIVPNexpo-
sure will result in offspring that exhibit altered sensitivity to the
rewarding and aversive effects of METH using two condition-
ing procedures: drug self-administration and conditioned taste
aversion (CTA). Previous research shows that PN-exposed off-
spring exhibited altered responding for IV nicotine (Levin et al.,
2006) and IV cocaine (Franke et al., 2008), according the drug
self-administrationprocedure.Todate,noexperimentshavedeter-
mined the effects of PN on the rewarding or aversive effects of
METH in offspring. Investigating METH is of interest because
amphetamines alter synaptic monoamine levels in the mesocor-
ticolimbic system differently than other abused drugs, such as
nicotine and cocaine. Amphetamines redistribute DA and other
monoamines from the presynaptic terminal to the synapse by
producing neurotransmitter release from vesicular monoamine
transporters; by inhibiting monoamine oxidase, and by reversing
DAtransporterfunction(Sulzeretal.,2005).Cocaineandnicotine
increase synaptic DA levels by blockade of the DA transporter and
nicotinic receptor stimulated DA release, respectively (Laviolette
and van der Kooy, 2004; Gether et al., 2006).
Two separate experiments were therefore conducted to deter-
mine if PN offspring exhibit altered appetitive or aversive condi-
tioning to METH during adulthood. In experiment 1,PN animals
prenatally exposed to IV nicotine were trained to self-administer
METH (0.05mg/kg/infusion) according to a FR schedule of rein-
forcement. Animals were then tested on multiple doses of IV
METH,rangingfrom0.0005to1.0mg/kg/infusion,toassessadult
offspring’s sensitivity to the reinforcing effects of the drug. Exper-
iment 2 determined if IV PN exposure alters acquisition and/or
extinction of METH-induced CTA, the standard method used
to assess the aversive effects of an unconditioned stimulus (US).
Potential differences in the sensitivity to the aversive effects of
METH were of interest because the trajectory for the escalation
of drug use may be determined, in part, by the relative response
to the aversive and rewarding effects of a drug (Davis and Riley,
2010). This is the ﬁrst experiment to assess drug-induced CTA in
offspring of PN exposure. Adult offspring consumed a saccharin
conditional stimulus (CS), which was paired with the METH US
(0,0.3,or0.56mg/kg;sc)toproduceCTAlearning,andextinction
of the conditioned response (CR) was measured, as well.
MATERIALS AND METHODS
ANIMALS
A total of 80 female and 30 male adult, nulliparous Sprague-
Dawley rats were acquired from Harlan Industries, Inc., (Indi-
anapolis, IN, USA). All rats were transported to the animal care
facilities in the psychology department at the University of South
Carolina and rodent food (ProLab Rat/Mouse/Hamster Chow
3000) and water were provided ad libitum throughout the course
of the experiments, except when otherwise speciﬁed. All ani-
mal cages were provided with Nylabones (Nylabone, Inc.; long
lasting durable chew-original; Neptune, NJ, USA) and Nestlets
(NestletsT; Ancare, Bellmore, NY, USA), for purposes of envi-
ronmental enrichment throughout the duration of the study. A
Nylabonewasreplacedif itwasthoroughlychewed,andoneNest-
let nesting product was placed in the animals’ cage when the
cage was changed, which occurred 2/week. The animal colony
was maintained at 212˚C, 5010% relative humidity, and a
12L:12D cycle with lights on at 07:00hours. The protocol for this
research methodology was approved by the Institutional Animal
Care and Use Committee (IACUC) at the University of South
Carolina.
BREEDING
Following a 7-day habituation period, female rats were housed
three per cage, and one male was placed with each triad from
approximately 17:00–09:00.Vaginal lavage samples were analyzed
daily with a microscope to determine if a sample was sperm-
positive. When a sample was identiﬁed as sperm-positive, the
corresponding female was single-caged and that day was consid-
ered gestational day (GD) 0. The weights of the pregnant dams
were recorded daily during pregnancy.
SURGERY: INDWELLING, INTERIORIZED JUGULAR CATHETERS
The internalized jugular catheters used in the present experiment
are commercially available from Harlan Industries. The catheter-
ization was performed at Harlan Industries (Indianapolis, IN,
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USA) according the methods of Mactutus et al. (1994) prior to
breeding.Brieﬂy,animalswereanesthetizedwithamixtureofketa-
mine hydrochloride (100mg/kg/ml) and xylazine (3.3mg/kg/ml).
Following anesthesia a sterile Intracath IV catheter (Becton,Dick-
insonandCo.,FranklinLakes,NJ,USA)withaLuer-Lokinjection
cap (Medex, Inc., Carlsbad, CA, USA) was implanted dorsally
in a subcutaneous pouch. The distal end of the catheter was
inserted into the left jugular vein, advanced toward the heart,
and the catheter was bound with sterile suture. Animals were
kept under periodic post-operative observation and returned to
the colony upon recovery. On the day following surgery,catheters
were ﬂushed with 0.2ml of heparinized saline.
PN AND PS ADMINISTRATION
Pregnant dams were randomly assigned to either the PN
(0.05mg/kg/ml) or PS groups. Nicotine or saline was adminis-
tered 3/day via internalized IV catheters from GD 8–21. An
organism’s susceptibility to a teratogen can vary depending on
the stage of development (Vorhees, 1986). Implantation occurs
on approximately GD 6, and teratogens generally have an all-or-
none effect on the organism during the preimplantation phase of
development, which is considered to be approximately GD 1–7.
GD 8–21 was chosen as the period of IV nicotine administration
because this time includes the initial stages of neurogenesis and
migration,synaptogenesis,gliogenesis,andmyelination.Thus,this
period represents a window of prenatal susceptibility for nico-
tine’s teratogenic effects on neural development (Dwyer et al.,
2008). Intravenous injections were delivered through the Luer-
Lok injection cap of the subcutaneously implanted injection port.
Following the ﬁrst and second injections catheters were “post-
ﬂushed” with 0.2ml of 0.9% physiological saline because 0.2ml
represents the approximate volume of the catheter. Post-ﬂush of
0.2ml of heparinized saline was used to ﬂush the catheter and
to maintain catheter patency after the third, daily nicotine injec-
tion. All IV nicotine, saline, and post-ﬂush injections were 20s
in duration. All injections were performed during the light por-
tion of the photoperiod,and injections were administered daily at
approximately 1000, 1300, and 1600.
SURROGATE FOSTERING, LITTER COMPOSITION, AND POSTNATAL
TESTING
The day of birth was considered postnatal day (PND) 0. On PND
1litters were culled to 10 with ﬁve males and ﬁve females when-
everpossible.Allpupsweresurrogate-fosteredtotimed-pregnant,
drug naïve dams to prevent poor maternal care (Vorhees, 1986).
Thedevelopmentalmilestonesof therightingreﬂex,negativegeo-
taxis,andeyeopeningwasassessedon PND3–5,8–10,and13–17,
respectively. For each experiment, only one male and one female
randomlyselectedfromeachlitterwereassignedtoeachtreatment
group (Holson and Pearce,1992). The righting reﬂex was assessed
by placing animals on their backs; upon releasing the animals the
latency to right themselves to their stomachs was recorded. The
righting reﬂex was assessed in blocks of three trials across three
consecutive days with a maximum latency of 25s per trial. Dur-
ing negative geotaxis testing animals were placed on a wire mesh
grid,positioned in a 25˚ downward angle. The latency (30s maxi-
mum) for animals to turn 180˚ to face up the slope was recorded.
Negative geotaxis was measured in blocks of three trials across
three consecutive days. Each animal’s eyes (left and right) were
checked for degree of openness across ﬁve consecutive days. The
degree of openness was rated on a scale of 0–3: 0Dcompletely
closed; 1Dany opening exposing the cornea, regardless of how
small; 2Dcornea and pupil are exposed but eye lids are not fully
open; 3Dfully open. All animals’ weights were recorded on PND
1, 7, 14, and 21. Rats were weaned and pair housed, same sex, on
PND 21.
EXPERIMENT 1: METH SELF-ADMINISTRATION
APPARATUS
Operant chambers (ENV-008; Med-Associates, St. Albans, VT,
USA), housed within sound-attenuating enclosures, were con-
trolled by Med-PC computer interface software. The front and
back panels of the chamber were stainless steel and the sides and
top were constructed of polycarbonate. The front panel of the
chamber allowed access to a recessed food dipper (ENV-202M)
through a 5-cm5-cm opening. Two retractable metal levers
(ENV-112BM) on either side of the opening were located 7.3cm
above a metal grid ﬂoor. A dipper equipped with a 0.1-ml cup
attached to the end of the dipper arm was raised into the food
receptacle, which allowed access to sucrose following the com-
pletion of a response requirement. A 28-V white cue light, 3cm
in diameter, located above each response lever was used to sig-
nal time-outs. An infrared sensor (ENV-254-CB) was used to
detect head entries into the food receptacle. During drug self-
administration sessions a syringe pump (PHM-100) was used
to deliver intravenous infusions through a water-tight swivel
(PHM-115).
SUCROSE-MAINTAINED RESPONDING: PRELIMINARY TRAINING
Prenatal nicotine (n D13 males; n D9 females) and PS (n D9
males; n D7 females) offspring were food restricted in order to
maintain 85% of free-feeding weight for 3days prior to the begin-
ning of dipper training. Dipper training and autoshaping were
conducted according to previous research (Reichel et al., 2008;
Lacy et al., 2012). Sucrose (26% w/v), was used as the reinforcer
during initial training sessions. Offspring were between 65 and
75days of age at the beginning of preliminary training.
SUCROSE-MAINTAINED RESPONDING: FR TRAINING
Both levers were presented in the chamber, and rats learned to
respond for continuous reinforcement during 30-min sessions. A
response on the active lever resulted in 4s of access to sucrose,
whereas responding on the inactive lever was recorded, but not
reinforced. After the ﬁrst day on continuous reinforcement, food
was returned to the animal’s home cage allowing ad libitum access
for the remainder of the experiment. Animals were maintained
on the FR-1 schedule for 1day and then transitioned to a FR-3
for 2days. Stable responding was operationally deﬁned as greater
than 2:1 ratio of active to inactive responses, and a minimum of
50 reinforcements by the second day of FR-3.
SURGERY: INDWELLING, EXTERIORIZED CATHETERS
Following acquisition of operant responding for sucrose reward
animals were allowed to free-feed for a minimum of 5days before
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undergoing catheterization surgery. Animals were anesthetized
with ketamine (100mg/kg/ml) and diazepam (5mg/kg/ml) then
implanted with a catheter into the right jugular vein. The catheter
exited through a dental acrylic head mount. The head mounts are
securedtotheskullwithmetalscrewsaccordingtothemethodsof
Harrodetal.(2001).Animalswereallowedtorecoverfromsurgery
for a minimum of 6days during which time their catheters were
ﬂushed with heparinized saline (0.2%). Animals were weighed
daily in order to monitor post-operative recovery.
METH SELF-ADMINISTRATION: FR TRAINING
During 60-min sessions, both the right and left levers were pre-
sentedintheoperantchamber.ForFR-1trainingeachresponseon
the active lever resulted in a 5.9-s, intravenous infusion of METH
(0.05mg/kg/infusion), which delivered approximately 0.1ml of
solution. Responding on the inactive lever was recorded but not
reinforced. A 20-s signaled time-out,i.e.,the illumination of both
cue lights, was initiated with the onset of the syringe pump. Ani-
malswerenotreinforcedforrespondingoneitherleverduringthe
signaledtime-out.AnimalsweremaintainedontheFR-1schedule
for a minimum of 5days. Once stable responding was exhibited,
animals were transitioned to a FR-3 schedule of reinforcement.
Stablerespondingwasoperationallydeﬁnedaslessthan20%vari-
ability of active lever responding across two consecutive sessions,
greater than 2:1 ratio of active to inactive responses, and a mini-
mumof10reinforcementspersession.Offspringwere95–105days
old when METH self-administration began.
FR TESTING
After animals had displayed two consecutive days of stable
responding on a FR-3 schedule the rats began testing on
the same schedule for ﬁve different concentrations of METH.
The concentrations were 0.0005, 0.0025, 0.005, 0.025, and
0.1mg/kg/infusion, which were presented according to a Latin-
squaredesign.AnimalsreturnedtoaFR-3scheduleandresponded
for 0.05mg/kg/infusion for a minimum of 1day between each FR
testingsession,andthesewerereferredtoasmaintenancedays.All
sessions were a maximum of 1h in length.
EXPERIMENT 2: METH-INDUCED CTA
MATERIALS
Duringtestingsessionsanimalsreceivedaccesstowaterorsucrose
via 100ml graduated cylinders equipped with a #6.5 rubber stop-
per and 2.500 straight drinking tube on the home cage (OT-100;
Ancare, Bellmore, NY, USA). During the water recovery period
standard drinking bottles were used.
PROCEDURE
Acquisition
Conditioned taste aversion was assessed using 124 adult ani-
mals, 65 males, and 59 females. Offspring were between 92 and
114days of age at the beginning of the experiment. Two doses
of METH (0.3 and 0.56mg/kg/ml) were injected subcutaneously
(sc) as the US. Control animals were injected with saline (Sal; sc)
rather than METH. Animals were assigned to one of the follow-
ingsixgroups:PS-0.3(male,n D11;female,n D9),PN-0.3(male,
n D11;female,n D11),PS-0.56(male,n D11;female,n D9),PN-
0.56 (male, n D11; female, n D11), PS-Sal (male, n D10; female,
n D9), PN-Sal (male, n D11; female, n D10). All rats received
water restriction for 4days prior to conditioning. During water
restrictionratsweregivenaccesstowaterfor15min/dayin100ml
graduated cylinders. Conditioning began on day 5. Animals were
presented with the saccharin (0.1% w/v) CS for 30min, and were
then injected with either METH 0.3 or 0.56mg/kg as the US or
Sal. On day 6,animals were given access to regular drinking water
in standard bottles for 30min, and no injections were adminis-
tered following water consumption. This procedure was repeated
three times in total. Thus, rats were conditioned on days 5, 7, and
9, and water recovery days occurred on days 6, 8, and 10. CS-US
pairings occurred between 1400 and 1800. The dependent mea-
sure was the amount saccharin consumed on each of the three
conditioning days. Saccharin consumption was weight-corrected
[(ml consumed)/(body weight in grams)] because of the baseline
sex difference in body weight.
Extinction
Repeated exposureto the CSin the absence of the US willresult in
a progressive attenuation of the CR. In order to generate extinc-
tioncurvesforthePSandPNrats,allanimalswereadministereda
daily,two-bottletestondays11–24.Duringtwo-bottletesting,the
bottles contained either water or saccharin, and the bottles were
placed on the cage in a balanced manner across groups. Animals
were given access to the bottles for 30min. Preference scores were
derived by dividing the amount of saccharin consumed by the
combined amount of saccharin and water consumed. The scores
derived from this measure range from 0 to 1.0. Scores greater
than 0.5 indicate a preference for saccharin, and scores below 0.5
show a preference for water. Males and females from each prena-
tal treatment and drug treatment were represented during each
of the conditioning and testing sessions. Extinction tests occurred
between 1400 and 1800.
DRUGS
Nicotine hydrogen tartrate and METH hydrochloride were
acquired from Sigma-Aldrich Pharmaceuticals (St. Louis, MO,
USA). Nicotine (base weight) and METH (salt weight) were dis-
solved in physiological saline (0.9%; Hospira, Inc., Lake Forest,
IL, USA). The pH of the nicotine solution was neutralized to
approximately 7.0 with NaOH. Heparin (APP Pharmaceuticals,
Schaumburg, IL, USA) was added to saline and the heparinized
saline solution (2.5%) was used to ﬂush the IV catheters.
DATA ANALYSIS
General: litter parameters
Thebetween-subjectsfactorsforthelitterparameteranalyzeswere
SexandPrenataltreatment(PNorPS).Thewithin-subjectsfactors
were PND and GD. A one-way analysis of variance (ANOVA) was
conductedforthetotalnumberofpupsborntoPNandPSdams.A
SexPrenatalTreatmentfactorialANOVAwasusedtoanalyzethe
ratioofmalestofemalesborntoPNandPSdams.ASexPrenatal
TreatmentPND mixed-factorialANOVA was conducted for the
pupweightgain,rightingreﬂex,negativegeotaxis,andeyeopening
data. A Prenatal TreatmentGD mixed-factorial ANOVA deter-
mined if there were differences between PS and PN dams on the
measure of maternal weight gain.
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Experiment 1: METH self-administration
The dependent measure for the METH self-administration study
was active lever presses. Analysis of the FR-3 testing data utilized
a 225 mixed-factorial ANOVA. The between-subjects fac-
tors were Prenatal Treatment and Sex, and the within-subjects
factor was Dose (METH dose; 0.0005, 0.0025, 0.005, 0.025,
0.1mg/kg/infusion). The same factorial ANOVA was also con-
ducted on the inactive lever data. These analyses were considered
signiﬁcant at p <0.05.
Experiment 2: METH-induced CTA
The acquisition data were analyzed with a 2233 mixed-
factorial ANOVA. The between-subjects factors were Prenatal
Treatment,Sex,andDose(0,0.3,0.56mg/kgMETH).Thewithin-
subjects factor was Day,which represents the 3-days of condition-
ing trials. The dependent measure for the acquisition data was
saccharin consumption (ml/g). Because there was a signiﬁcant
main effect of sex on the weight-corrected data, which indi-
cates that females consumed more saccharin relative to males,
the percent of control data were analyzed with a 2232
mixed-factorial ANOVA (the factor of dose was reduced to two)
in order to account for the baseline sex difference in saccharin
consumption.
A 22314 mixed-factorial ANOVA was used to ana-
lyze the two-bottle, extinction data. The between-subjects factors
were Prenatal Treatment, Sex, and Dose. The within-subjects fac-
tor was Day. For the extinction data, the dependent measure was
saccharin preference score [(saccharin)/(saccharinCwater)]. Fol-
lowing a signiﬁcant DoseDay interaction, dependent t-tests
were conducted on days 1 and 14 of extinction to conﬁrm if
animals in the SAL, METH 0.3, and METH 0.56 groups exhib-
ited a change in preference, i.e., extinction, from day 1 to day
14. Dunnett’s tests (Bonferroni correction),which compare treat-
ment groups to a single control, were conducted on day 14 data
to determine if the preference scores exhibited by the METH 0.3
and METH 0.56 groups differed from controls. These analyses
are important to determine if treatment groups exhibited full
or partial extinction. All analyzes were considered signiﬁcant at
p <0.05.
RESULTS
LITTER PARAMETERS
Data gathered from the PN and PS-exposed pups revealed no sig-
niﬁcant effect of prenatal treatment on the number of pups born,
theratioof malevs.femalepups,rightingreﬂex,negativegeotaxis,
or eye opening (data not shown). Further, there was no signiﬁ-
cant effect of Prenatal Treatment on dam weight gain (Figure1A)
or pup weight gain (Figure 1B). These ﬁndings indicate that PN
exposure did not disrupt postnatal development according to the
ontogenetic measures used in the present study.
EXPERIMENT 1: METH SELF-ADMINISTRATION
A 225 mixed-factorial ANOVA revealed main effects of
Dose [F(1, 34)D43.6, p <0.001] and Prenatal Treatment [F(1,
34)D4.3, p <0.05], and a signiﬁcant DosePrenatal Treat-
ment interaction [F(1, 34)D4.9, p <0.05]. Sex was not a sig-
niﬁcant factor in the analyses. The METH self-administration
data are presented as two separate dose-response curves in
Figure 2. As can be seen in Figure 2, varying the unit dose
of IV METH produced the standard “U” shaped curve for the
PN and PS groups, which is commonly observed when animals
self-administer psychostimulant drugs, such as amphetamines
or cocaine (Yokel, 1987). Furthermore, the PS and PN groups
exhibited similar means of active lever presses when allowed
to respond for the lowest and highest unit doses of IV METH
tested. However, PS rats clearly showed peak responding at the
0.025-mg/kg/infusion dose, whereas the PN animals exhibited
peak responding between the 0.005- and 0.025-mg/kg/infusion
doses. The main effect of Prenatal Treatment indicates that PN
animals responded more for METH compared to the PS rats.
The signiﬁcant DosePrenatal Treatment interaction indicates
that the PN dose-response curve shifted to the left. Analysis of
inactive lever responding revealed a signiﬁcant effect of Dose
[F(1, 34)D26.9, p <0.001] and no other signiﬁcant effects were
found. The means (SEM) for inactive lever responding were
10.0 (1.6), 8.9 (1.3), 6.5 (0.9), 5.0 (0.8), and 3.9 (0.6;
data not shown) for the 0.0005, 0.0025, 0.005, 0.025, and 1.0
doses, respectively. The main effect of dose shows that rats
responded more on the inactive lever when the dose was 0.0005
FIGURE 1 | (A) Mean (SEM) weight gain data for the Saline and Nicotine dams across gestation. (B) Mean (SEM) weight gain data for the PN and PS pups
across PND 1–21.
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and responding on this lever decreased as the unit dose of METH
increased.
These results indicate that the PN rats exhibited a leftward
shift in the dose-response curve relative to rats in the PS treat-
ment group. This indicates that PN rats were more sensitive to the
reinforcing effects of IV METH compared to the PS animals.
EXPERIMENT 2: METH-INDUCED CTA
Acquisition of CTA
A SexPrenatal TreatmentDoseDay (2233) mixed-
factorial ANOVA was conducted on the weight-corrected data.
The analysis revealed a main effect of Sex: [F(1, 224)D114.9,
p<0.001],whichindicatesthatfemalesconsumedmoresaccharin
relative to males. According to this analysis females consumed an
average of 0.06ml/g of saccharin (SEMD0.001), whereas males
consumed an average of 0.04ml/g of saccharin (SEMD0.001;
data not shown). Percent of control values were calculated, and
a SexPrenatal TreatmentDoseDay (2223) mixed-
factorial ANOVA was conducted on these data in order to
adequately assess potential sex differences in CTA. The analy-
sis revealed no signiﬁcant effects of Sex or Prenatal Treatment.
Figure 3 shows the acquisition curves (% of control) for PN
and PS groups injected with METH 0.3 or 0.56mg/kg by condi-
tioning trials. The PN and PS groups represent both males and
females; however, the factors of Prenatal Treatment are repre-
sentedonFigure3becauseprenataltreatmentwasthefocusof the
experiment.Thesigniﬁcantmaineffectof Dayshowsthatanimals
treated with the METH US exhibited decreased saccharin con-
sumption as a function of conditioning day [F(2, 152)D484.8,
p<0.001] and the main effect of Dose indicates that overall
the magnitude of CTA was greater in the METH 0.56mg/kg
group [means (SEM)D0.667 (0.018)], relative to the METH
FIGURE 2 | Mean (SEM) active lever responses for the PS and PN
groups are presented for the METH doses 0.0005, 0.0025, 0.005, 0.025,
0.05, and 0.1mg/kg/injection according to a log10 scale. Data from the
training dose, 0.05mg/kg/injection, is shown on the graph as a point of
reference, but was not included in the ANOVA.This point represents the
average responding for 0.05mg/kg/infusion METH from the day before
testing with the 0.0005- to 0.1-mg/kg/infusion doses. PN animals showed a
leftward shift of the dose-response curve relative to the PS rats [Prenatal
TreatmentDose interaction; F(1, 34)D4.9, p <0.05].
0.3mg/kg group [0.798 (0.018); F(1, 76)D26.9, p<0.001].
Moreover, repeated saccharin-METH pairings produced a pro-
gressive increase in the magnitude of CTA, and greater avoidance
behaviorwasobservedfromanimalsinjectedwiththehigherdose
of METH, according to the signiﬁcant DayDose interaction
[F(2, 152)D20.5,p<0.001].
Extinction of CTA
A 22314 mixed-factorial ANOVA was conducted on the
extinction data. There were no signiﬁcant main effects or inter-
actions with the factors of Sex or Prenatal Treatment. Figure 4
shows the saccharin preference data for the PN and PS groups
injected with SAL or METH 0.3 or 0.56mg/kg US as a function
of extinction trials. The PN and PS groups represent both males
and females; however,the factors of Prenatal Treatment are repre-
sentedonFigure4becauseprenataltreatmentwasthefocusof the
study.Scoresabove0.5indicateapreferenceforsaccharin,whereas
scores below 0.5 indicate a preference for water.
According to the signiﬁcant main effect of Dose [F(2,
112)D103.8,p<0.001],differentmagnitudesof CTAwereexhib-
ited by animals treated with SAL, METH 0.3, and METH
0.56mg/kg. Thus, overall, rats treated with SAL or METH
0.3mg/kg exhibited saccharin preference of 0.86 (0.03) and
0.58 (0.03), respectively; whereas the METH 0.56mg/kg group
showed an overall water preference 0.29 (0.03). The main effect
of Day [F(13, 1456)D38.9, p<0.001] shows that preference
scores changed following repeated, non-reinforced exposure to
the saccharin/water test stimuli; and the DayDose interaction
[F(26, 1456)D7.5, p<0.001] indicates that the preference scores
changed across testing days and was dependent on whether the
conditioning dose was 0.3 or 0.56mg/kg.
In order to assess responding following repeated, non-
reinforced exposure to the CS, within-subjects comparisons
FIGURE 3 | Mean (SEM) percent of control saccharin consumption
(ml/g) data from the acquisition phase of the experiment.The CS was
saccharin (0.1%, w/v) and the US was METH (SAL, 0.3 or 0.56mg/kg). Data
are shown as percent of control for the PS and PN animals treated with
METH across conditioning days 1–3.There were no signiﬁcant effects or
interactions with the factor of PrenatalTreatment or Sex.
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FIGURE 4 | Mean (SEM) preference scores for the 14 consecutive
two-bottle extinction tests are presented for the PS and PN animals
that were treated with either SAL or 0.3mg/kg METH (A) or SAL or
0.56mg/kg METH (B). Scores above 0.5 indicate a preference for
saccharin and scores below 0.5 indicate a preference for water.There
were no signiﬁcant effects or interactions with the factor of Prenatal
Treatment or Sex. Signiﬁcant differences between days 1 and 14 are
indicated by * (p <0.001). Signiﬁcant differences between SAL and the
0.3- and 0.56-mg/kg METH groups are indicated by
^ (p <0.05) and
^^
(p <0.001).
between day 1 and 14 were conducted for the SAL, METH 0.3,
and METH 0.56 groups, as described by the DayDose inter-
action. Animals in the SAL group showed a consistent prefer-
ence for saccharin between testing days 1 and 14 [t(39)D1.49,
p>0.05]. Rats treated with METH 0.3 initially showed a prefer-
ence for water on day 1, and repeated exposure to the CS/water
resulted in extinction, which is represented as a saccharin prefer-
ence on day 14 [t(41)D9.37, p<0.001]. The change in respond-
ing represents a 91% increase in the preference score. Animals
in the METH 0.56 group exhibited a preference for water on
day 1, and despite a similar 91% increase in preference score,
these animals maintained an overall preference water on day 14
[t(41)D4.62, p<0.001; Figure 4]. Dunnette’s tests were con-
ducted for data from the three groups on day 14 to determine
if either the METH 0.3 or 0.56 groups were different than con-
trols on the ﬁnal day of extinction training. The preference scores
from both the METH 0.3 and 0.56 groups were signiﬁcantly lower
than the SAL group (p<0.05 and p<0.001, respectively). These
ﬁndings show that non-reinforced presentation of the CS pro-
duced extinction of the CR for both doses of the METH US
and 14days of extinction did not fully extinguish the CR rela-
tive to the SAL controls. These data indicate that PN exposure
did not result in differential acquisition or extinction of METH-
induced CTA when rats were conditioned and tested during
adulthood.
DISCUSSION
The present experiments determined if IV PN exposure altered
thereinforcingand/oraversiveeffectsof METHinadultoffspring.
In experiment 1, PS and PN rats were trained to self-administer
METH according to a FR-3 schedule of reinforcement. Following
stableresponding,ratsweretestedonvaryingdosesof METHand
dose-response curves were generated for both groups. Although
both the PN and PS treatment groups exhibited the standard“U”-
shapeddose-responsecurve(Yokel,1987),PNratsexhibitedmore
active lever responses for doses of METH,relative to controls. The
leftward shift in the PN rats’ dose-response curve, as indicated
by a signiﬁcant main effect of prenatal treatment and a prenatal
treatmentdose interaction, indicates that these animals were
more sensitive to the reinforcing effects of METH compared to
rats in the PS group.
The enhanced sensitivity to IV METH exhibited by offspring
in the present study may be related to nicotine’s ability to induce
transcriptional activation of genes associated with drug reward
and sensitization of the mesocorticolimbic system (Zhu et al.,
2007; Levine et al., 2011). In a study by Levine et al. (2011), mice
were preexposed to oral nicotine or water and then were treated
with either saline or cocaine. Nicotine-treated mice exhibited
enhanced cocaine-induced locomotor sensitization and cocaine-
mediated conditioned place preference, and increased cocaine-
induced expression of accumbal FosB relative to controls that did
not receive nicotine treatment. The nicotine-mediated increase
in cocaine-induced FosB expression was associated with changes
in histone acetylation, suggesting an epigenetic explanation of
the ﬁndings (Levine et al., 2011). These and other ﬁndings sug-
gest that PN may modulate histone acetylation of FosB during
neurodevelopment,potentiallyleadingtoalterationsinothertran-
scription factors, and D1 mediated signaling proteins (Teegarden
etal.,2008).Indeed,previousresearchdemonstratesthatPNalters
MAPkandPI3ksignalingpathways(Weietal.,2011)andincreases
levels of mRNA and protein of brain-derived neurotrophic factor
throughoutthemesocorticolimbicDAsystem(Harrodetal.,2011;
Weietal.,2011).Thus,determiningtheeffectsof IVPNonhistone
acetylation at FosB expression in offspring is of interest for future
investigation.
Adolescent offspring of continuous PN exposure were pre-
viously reported to exhibit altered responding for IV cocaine.
In that study Franke et al. (2008) investigated cocaine self-
administration using two different concentrations of the rein-
forcer, 200 or 500mg/kg/infusion, and focused on the acquisition
of FR-1 responding using adolescent offspring. These ﬁndings are
importantbecausetheydemonstratethatratstreatedwithcontin-
uous PN acquired self-administration at different concentrations
of cocaine: PN-treated rats acquired stable responding when the
concentration was 500, but not 200mg/kg/infusion, whereas the
opposite relationship was observed for controls. Thus, these data
show that PN rats required a concentration of cocaine that was
2.5 times higher than the dose needed for controls to acquire the
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response. Thus, the Franke et al. (2008) experiment suggests that
during the developmental period of adolescence, the PN animals
werelesssensitivetothestimuluspropertiesof IVcocainethanPS
offspring.
The present experiment focused on changes in the relative sen-
sitivity to IV METH after adult offspring acquired stable respond-
ing on a FR-3 schedule of reinforcement. Thus, offspring were
tested intermittently with various novel doses of the reinforcer
after maintenance of the CR was demonstrated. That adult PN
rats self-administered a lower dose of METH relative to controls
demonstrates that PN exposure alters the stimulus properties of
IV METH. Moreover, these effects of IV PN exposure appear to
endure,as offspring did not receive exposure to any drug between
birth and METH self-administration, which began during adult-
hood. This is an important point because nicotine exposure dur-
ing adulthood can alter gene expression and this can lead to an
altered response to other drugs of abuse, such as cocaine (Levine
et al., 2011). Further experiments need to determine if PS and
PN animals show differences in METH self-administration when
progressive-ratioschedulesofreinforcementareused(Richardson
and Roberts,1996). Such data will be necessary to determine if IV
PNexposureresultsinmotivationaldifferencesforthereinforcing
effects of METH. Moreover, these ﬁndings suggest that PN expo-
suremayalterthefunctionofvariousmoleculartargetsforMETH,
such as VMAT and DAT, through which this drug changes synap-
tic monoamine levels (Dwoskin and Crooks, 2002). Overall, PN
exposure alters the appetitive stimulus properties of psychostim-
ulant drugs like cocaine, nicotine, and METH, and these ﬁndings
suggest that such alterations in the reinforcing effects of abused
drugscouldbeonefactorthatunderliestheincreasedvulnerability
to drug abuse that is documented in offspring of in utero tobacco
smoke exposure.
The aversive effects of abused drugs may play an important
role in offsetting the transition from recreational drug use to
chronic drug taking behavior (see Davis and Riley, 2010). Pre-
clinical research shows that nicotine exposure during early stages
ofdevelopment(e.g.,periadolescence)canalterlearningaboutthe
aversive effects of abused drugs in adulthood (Rinker et al.,2011).
ThereforeitwasalsoofinteresttodetermineifPNexposureaffects
the acquisition and expression of METH-induced CTA. Experi-
ment 2 showed that PN exposure did not alter METH-induced
CTA. PN and PS animals acquired CTA in a dose-dependent
manner and both treatment groups exhibited similar magnitudes
of conditioned responding, as measured by the acquisition and
extinctionprocedures.Thus,PNexposuredidnotaltertheaversive
effects of METH when measured by the CTA procedure. Further
research needs to determine if a higher dose of IV PN will impact
the acquisition and expression of METH-induced CTA in off-
springinordertofullydetermineif inutero nicotineexposurecan
alter learning about the aversive effects of METH.
Low birth weight in offspring of maternal smoking is well doc-
umented (Ernst et al., 2001). These effects are produced, in part,
from nicotine, because PN exposure alone produces lower birth
weightsinexposedrodentoffspringrelativetocontrols.Thiseffect
has beenobserved inanimal models usingthe continuous,IV,and
drinking water methods of nicotine exposure (e.g., Slotkin, 2004;
LeSageetal.,2006;Levinetal.,2006;Schneideretal.,2010),andin
general,the differences in weight are resolved with maturity. Low-
eringthedoseofPNavoidsbirthweightdeﬁcitsinoffspringacross
all of the abovementioned exposure models (e.g., Franke et al.,
2008; Schneider et al., 2010; Harrod et al., 2011), yet these studies
report neurochemical and behavioral alterations in the offspring.
The low dose,IV model of PN administration used in the present
experiment has not produced altered birth weight or weight gain
inoffspring(Harrodetal.,2011;Lacyetal.,2011,2012),according
tothedescribedprocedures.Thecurrentﬁndingsaddtoagrowing
literature,whichshowsthatPNexposureproducesneurochemical
and behavioral changes in offspring born of normal birth weight
(Paulyetal.,2004;Frankeetal.,2007,2008;Schneideretal.,2010).
Taken together, the present ﬁndings indicate that IV PN expo-
sure altered the stimulus properties of METH when an appetitive
conditioning procedure was used. This ﬁnding adds to a growing
literature, which shows that IV PN can alter the behavior of off-
spring in later stages of development (LeSage et al., 2006; Harrod
etal.,2011;Lacyetal.,2011).AnadvantagetousingtheIVrouteof
administration is that IV injection allows for 100% bioavailability
of nicotine absorption and near instantaneous distribution. And,
as previously mentioned, the IV route of administration closely
mimics the pharmacokinetics of nicotine produced through cig-
arette smoke inhalation. Another advantage is that this exposure
method may be used to deliver less daily amounts of nicotine
relative to other exposure models (Russell and Feyerabend, 1978;
Mactutus,1989;Boozeetal.,1999;Benowitzetal.,2009).Lacyetal.
(2011) showed that the IV exposure method used in the present
study produced deﬁcits in prepulse inhibition of the acoustic star-
tle response that are consistent with that induced by a continuous
GN exposure model (i.e., Popke et al., 1997), for example. There
are clearly disadvantages to all methods of PN exposure. A dis-
advantage of the present model may be that it requires direct
interaction with the dam in order to administer the daily prenatal
injections.Ontheotherhand,thismethodaffordsauniqueoppor-
tunity to monitor the animals’ progression through pregnancy
without adding what would otherwise be considered additional
stress. Another disadvantage is that the present model uses nico-
tine to mimic maternal smoking when there are approximately
4,000 active compounds in cigarette smoke.
Thepresentexperimentsindicatethatoffspringof IVPNexpo-
sure showed increased sensitivity to the reinforcing effects of the
highlyabuseddrugMETH.Thisﬁndingsuggeststhatwomenwho
smoke a “low” number of daily cigarette during pregnancy may
alter the development of motivational systems in their offspring.
Increased sensitivity to the reinforcing properties of abused drugs
may be one important factor that mediates the increased vulner-
ability toward substance abuse in the offspring of women who
smoke tobacco throughout pregnancy.
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